|
SLNO Soleno Therapeutics Inc 1484565 |
| Balance Sheet |
|
Current Assets
|
293,889,000 |
|
Assets
|
330,972,000 |
|
Current Liabilities
|
18,747,000 |
|
Liabilities
|
85,859,000 |
|
Equity
|
245,113,000 |
|
Shares Out
|
51,624,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-69,096,000 |
|
Investing Cash Flow
|
-225,682,000 |
| Market Analysis |
Market Cap
|
2,728,131,885 |
|
Price
|
52.75 |
|
BVPS
|
6.31 |
|
PB
|
7.65 |
|
EPS
|
0.39 |
|
PE
|
134.96 |
|
PS
|
0.08 |
|
FCF
|
-294,778,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/28 |
-4.38 |
3/06 |
0.50 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SLNO documents filed with the SEC.
SLNO Filings
Clear
